Showing results (21-30 of 216) with videos related to
Sort By:
Pageof 22
Inflammatory Bowel Diseases|December 29, 2019
Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative ColitisDavid Kevans, Richard Kirsch, Callum Dargavel, et al.Journal of Crohn'S & Colitis|April 19, 2014
Future directions in inflammatory bowel disease managementGeert R D'Haens, R Balfour Sartor, Mark S Silverberg, et al.Journal of Crohn'S & Colitis|April 20, 2019
Differential miRNA Expression in Ileal and Colonic Tissues Reveals an Altered Immunoregulatory Molecular Profile in Individuals With Crohn's Disease versus Healthy SubjectsAylia Mohammadi, Orlaith B Kelly, Michelle I Smith, et al.Inflammatory Bowel Diseases|April 28, 2016
Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT StudyGeoffrey C Nguyen, Ken Croitoru, Mark S Silverberg, et al.Arthritis Care & Research|July 22, 2017
Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized Computed Tomography Scoring SystemJonathan Chan, Ismail Sari, David Salonen, et al.European Journal of Gastroenterology & Hepatology|March 18, 2021
Ustekinumab induction concentrations are associated with clinical and biochemical outcomes at week 12 of treatment in Crohn's diseaseMargaret Walshe, Krzysztof Borowski, Karen Boland, et al.Gut|May 28, 2026
From preclinical phase of Crohn's disease to postoperative recurrence: shared mechanisms and potential interventionsRirong Chen, Williams Turpin, Matthieu Allez, et al.Scandinavian Journal of Gastroenterology|November 22, 2013
Effect of inflammatory bowel disease therapies on immunogenicity of Mycobacterium paratuberculosis proteinsAnne Xia, Joanne M Stempak, Jesse Grist, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 29, 2018
Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activityEran Zittan, Orlaith B Kelly, Ian M Gralnek, et al.Inflammatory Bowel Diseases|May 13, 2017
Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel DiseaseOrlaith B Kelly, Sarah Oʼ Donnell, Joanne M Stempak, et al.Pageof 22